PubMed:23592772 / 0-112 JSONTXT

Annnotations TAB JSON ListView MergeView

    sentences

    {"project":"sentences","denotations":[{"id":"T1","span":{"begin":0,"end":109},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCa"}

    DisGeNET5_gene_disease

    {"project":"DisGeNET5_gene_disease","denotations":[{"id":"23592772-0#67#72#gene4790","span":{"begin":67,"end":72},"obj":"gene4790"},{"id":"23592772-0#67#72#gene4790","span":{"begin":67,"end":72},"obj":"gene4790"},{"id":"23592772-0#85#102#diseaseC0235974","span":{"begin":85,"end":102},"obj":"diseaseC0235974"},{"id":"23592772-0#85#102#diseaseC0346647","span":{"begin":85,"end":102},"obj":"diseaseC0346647"},{"id":"23592772-0#0#5#diseaseC0424295","span":{"begin":0,"end":5},"obj":"diseaseC0424295"}],"relations":[{"id":"67#72#gene479085#102#diseaseC0235974","pred":"associated_with","subj":"23592772-0#67#72#gene4790","obj":"23592772-0#85#102#diseaseC0235974"},{"id":"67#72#gene479085#102#diseaseC0346647","pred":"associated_with","subj":"23592772-0#67#72#gene4790","obj":"23592772-0#85#102#diseaseC0346647"},{"id":"67#72#gene47900#5#diseaseC0424295","pred":"associated_with","subj":"23592772-0#67#72#gene4790","obj":"23592772-0#0#5#diseaseC0424295"},{"id":"67#72#gene479085#102#diseaseC0235974","pred":"associated_with","subj":"23592772-0#67#72#gene4790","obj":"23592772-0#85#102#diseaseC0235974"},{"id":"67#72#gene479085#102#diseaseC0346647","pred":"associated_with","subj":"23592772-0#67#72#gene4790","obj":"23592772-0#85#102#diseaseC0346647"},{"id":"67#72#gene47900#5#diseaseC0424295","pred":"associated_with","subj":"23592772-0#67#72#gene4790","obj":"23592772-0#0#5#diseaseC0424295"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCa"}

    mondo_disease

    {"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":85,"end":102},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005192"},{"id":"A2","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0009831"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCa"}

    GlyCosmos15-HP

    {"project":"GlyCosmos15-HP","denotations":[{"id":"T1","span":{"begin":85,"end":102},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0002894"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCa"}

    GlyCosmos15-MONDO

    {"project":"GlyCosmos15-MONDO","denotations":[{"id":"T1","span":{"begin":85,"end":102},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005192"},{"id":"A2","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0009831"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCa"}

    GlyCosmos15-CL

    {"project":"GlyCosmos15-CL","denotations":[{"id":"T1","span":{"begin":96,"end":108},"obj":"Cell"}],"attributes":[{"id":"A1","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0001064"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCa"}

    sentences

    {"project":"sentences","denotations":[{"id":"T1","span":{"begin":0,"end":109},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCa"}

    GlyCosmos15-Sentences

    {"project":"GlyCosmos15-Sentences","blocks":[{"id":"T1","span":{"begin":0,"end":109},"obj":"Sentence"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCa"}

    HP-phenotype

    {"project":"HP-phenotype","denotations":[{"id":"T1","span":{"begin":85,"end":102},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0002894"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCa"}

    CL-cell

    {"project":"CL-cell","denotations":[{"id":"T1","span":{"begin":96,"end":108},"obj":"Cell"}],"attributes":[{"id":"A1","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0001064"}],"text":"Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.\nCa"}